• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in CO

tetano

Editor, Senior Moderator
Nat Commun


. 2023 Jul 25;14(1):4481.
doi: 10.1038/s41467-023-40076-5. Genetically diverse mouse models of SARS-CoV-2 infection reproduce clinical variation in type I interferon and cytokine responses in COVID-19

Shelly J Robertson[SUP] 1 2 [/SUP], Olivia Bedard[SUP] 3 [/SUP], Kristin L McNally[SUP] 1 [/SUP], Carl Shaia[SUP] 4 [/SUP], Chad S Clancy[SUP] 4 [/SUP], Matthew Lewis[SUP] 1 [/SUP], Rebecca M Broeckel[SUP] 1 [/SUP], Abhilash I Chiramel[SUP] 1 [/SUP], Jeffrey G Shannon[SUP] 2 [/SUP], Gail L Sturdevant[SUP] 1 2 [/SUP], Rebecca Rosenke[SUP] 4 [/SUP], Sarah L Anzick[SUP] 5 [/SUP], Elvira Forte[SUP] 3 6 [/SUP], Christoph Preuss[SUP] 3 [/SUP], Candice N Baker[SUP] 3 [/SUP], Jeffrey M Harder[SUP] 3 [/SUP], Catherine Brunton[SUP] 3 [/SUP], Steven Munger[SUP] 3 [/SUP], Daniel P Bruno[SUP] 5 [/SUP], Justin B Lack[SUP] 5 [/SUP], Jacqueline M Leung[SUP] 5 [/SUP], Amirhossein Shamsaddini[SUP] 5 [/SUP], Paul Gardina[SUP] 5 [/SUP], Daniel E Sturdevant[SUP] 5 [/SUP], Jian Sun[SUP] 5 [/SUP], Craig Martens[SUP] 5 [/SUP], Steven M Holland[SUP] 7 [/SUP], Nadia A Rosenthal[SUP] 8 9 [/SUP], Sonja M Best[SUP] 10 11 [/SUP]



Affiliations
Abstract

Inflammation in response to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection drives severity of coronavirus disease 2019 (COVID-19) and is influenced by host genetics. To understand mechanisms of inflammation, animal models that reflect genetic diversity and clinical outcomes observed in humans are needed. We report a mouse panel comprising the genetically diverse Collaborative Cross (CC) founder strains crossed to human ACE2 transgenic mice (K18-hACE2) that confers susceptibility to SARS-CoV-2. Infection of CC x K18-hACE2 resulted in a spectrum of survival, viral replication kinetics, and immune profiles. Importantly, in contrast to the K18-hACE2 model, early type I interferon (IFN-I) and regulated proinflammatory responses were required for control of SARS-CoV-2 replication in PWK x K18-hACE2 mice that were highly resistant to disease. Thus, virus dynamics and inflammation observed in COVID-19 can be modeled in diverse mouse strains that provide a genetically tractable platform for understanding anti-coronavirus immunity.


 
Back
Top Bottom